Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Bios-Therapy Physiological Systems For Health S P A maintains a patent portfolio in the Biotechnology & Pharmaceuticals technology area. The company currently has 1 pending office action. This single matter is assigned to 1 distinct examiner within 1 distinct art unit.
Qiuwen Mi is the busiest examiner for the portfolio, responsible for the 1 pending office action currently active. The alignment of 1 examiner and 1 art unit for the active matter indicates a very narrow and focused prosecution footprint for the company's current filings. This concentrated structure allows for a very specific review process within the biotechnology and pharmaceuticals field.
Practitioners should note that the company's current activity is limited to this 1 pending office action. Qiuwen Mi's role as the busiest examiner is a direct result of this limited volume. The presence of only 1 distinct art unit suggests that the company's current intellectual property efforts are focused on a specific technical niche. This singular point of contact for the 1 pending office action simplifies the prosecution landscape for the company's current assets.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| POHNERT, STEVEN C | 2 | 12.5% | +18.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19169541 | METHODS FOR DETERMINING WHEN A NATURAL THERAPEUTIC OR BENEFICIAL PRODUCT EXERTS ITS THERAPEUTIC OR BENEFICIAL EFFECT THROUGH A PHYSIOLOGICAL MODE OF ACTION | POHNERT, STEVEN C | — |
| 18970350 | METHODS FOR DETERMINING WHEN A NATURAL THERAPEUTIC OR BENEFICIAL PRODUCT EXERTS ITS THERAPEUTIC OR BENEFICIAL EFFECT THROUGH A PHYSIOLOGICAL MODE OF ACTION | POHNERT, STEVEN C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19169541 | METHODS FOR DETERMINING WHEN A NATURAL THERAPEUTIC OR BENEFICIAL PRODUCT EXERTS ITS THERAPEUTIC OR BENEFICIAL EFFECT THROUGH A PHYSIOLOGICAL MODE OF ACTION | POHNERT, STEVEN C | — |
| 18970350 | METHODS FOR DETERMINING WHEN A NATURAL THERAPEUTIC OR BENEFICIAL PRODUCT EXERTS ITS THERAPEUTIC OR BENEFICIAL EFFECT THROUGH A PHYSIOLOGICAL MODE OF ACTION | POHNERT, STEVEN C | — |
| Art Unit | Apps |
|---|---|
| 1683 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19169541 | METHODS FOR DETERMINING WHEN A NATURAL THERAPEUTIC OR BENEFICIAL PRODUCT EXERTS ITS THERAPEUTIC OR BENEFICIAL EFFECT THROUGH A PHYSIOLOGICAL MODE OF ACTION | POHNERT, STEVEN C | 1683 | §101§103§112 | Final Rejection | — | Pending | Apr 03, 2025 |
| 18970350 | METHODS FOR DETERMINING WHEN A NATURAL THERAPEUTIC OR BENEFICIAL PRODUCT EXERTS ITS THERAPEUTIC OR BENEFICIAL EFFECT THROUGH A PHYSIOLOGICAL MODE OF ACTION | POHNERT, STEVEN C | 1683 | §101§103§112 | Final Rejection | — | Pending | Dec 05, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBios-Therapy Physiological Systems For Health S P A has 2 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Steven C Pohnert has the most, with 2 of Bios-Therapy Physiological Systems For Health S P A's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
